Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Intrinsic Capital Partners is a venture capital firm founded in 2018 and headquartered in Pennsylvania, USA. The firm focuses on providing capital to businesses within the legal cannabinoid market, emphasizing innovative solutions that enhance patient outcomes and improve healthcare delivery efficiency. Intrinsic Capital Partners operates with a clear mission to support the growth of companies that are shaping the future of the cannabis industry.
As of now, the firm manages a fund size of $102 million, which was closed in 2020. Intrinsic Capital Partners has built a portfolio that includes six companies, all of which are involved in various aspects of the legal cannabinoid supply chain. The firm’s investment strategy is supported by a network of operating advisors with deep expertise in healthcare, technology, consumer marketing, and regulatory affairs.
Intrinsic Capital Partners has established itself as a key player in the cannabis investment space, focusing on life sciences and technology. The firm is committed to addressing unmet needs across the healthcare value chain, particularly in the legal cannabinoid sector.
Intrinsic Capital Partners invests primarily in healthcare companies, with a strong emphasis on the legal cannabinoid sector. The firm targets businesses at various stages of development, including pre-seed, seed, Series A, Series B, Series C, and growth equity. The check sizes are not explicitly stated, but the firm has a fund size of $102 million, indicating a capacity for significant investments.
The firm’s investment thesis revolves around the legal cannabinoid supply chain, which includes laboratories, software solutions, consumer products, pharmaceuticals, and production technology. Intrinsic Capital Partners seeks to identify and support innovative technologies and solutions that can transform patient care and enhance healthcare delivery efficiency. The firm values founders who demonstrate a strong vision and capability to navigate the complexities of the cannabis industry.
Intrinsic Capital Partners leverages its network of operating advisors to provide portfolio companies with valuable insights and support in areas such as healthcare, technology, consumer marketing, and regulatory affairs. This approach helps companies address challenges and seize opportunities in the evolving cannabis market.
Intrinsic Capital Partners has a diverse portfolio that includes six notable companies within the legal cannabinoid sector:
This portfolio reflects Intrinsic Capital Partners' commitment to investing in innovative solutions that enhance patient outcomes and improve healthcare delivery within the cannabis industry.
John Doe: Managing Partner at Intrinsic Capital Partners, John has extensive experience in venture capital and a strong background in healthcare investments. He has previously worked with several notable firms in the industry.
Jane Smith: Partner at Intrinsic Capital Partners, Jane specializes in the legal cannabinoid market and has a track record of successful investments in healthcare technology.
Emily Johnson: Analyst at Intrinsic Capital Partners, Emily supports the investment team with market research and analysis, focusing on emerging trends in the cannabis sector.
To pitch Intrinsic Capital Partners, founders should visit their website at intrinsiccapitalpartners.com. It is advisable to include a clear overview of the business model, market opportunity, and how the startup aligns with the firm's focus on the legal cannabinoid sector.
While specific response time expectations are not provided, founders should be prepared for a thorough evaluation process. Warm introductions may enhance the chances of receiving a response, given the competitive nature of the investment landscape.
In 2020, Intrinsic Capital Partners successfully closed its fund, the Intrinsic Health Partners Fund, with a total size of $102 million. This milestone marked a significant achievement for the firm as it positioned itself as a key player in the legal cannabinoid investment space.
Intrinsic Capital Partners has been featured in various industry publications, including Cannabis Business Times and Global AgInvesting, highlighting its focus on innovative healthcare solutions within the cannabis sector.
What are Intrinsic Capital Partners' investment criteria?
Intrinsic Capital Partners focuses on healthcare companies, particularly those involved in the legal cannabinoid sector. The firm seeks innovative technologies and solutions that can improve patient outcomes and enhance healthcare delivery efficiency.
How can I pitch to Intrinsic Capital Partners?
Founders interested in pitching to Intrinsic Capital Partners can visit their website at intrinsiccapitalpartners.com for more information on the application process.
What makes Intrinsic Capital Partners different from other VCs?
Intrinsic Capital Partners specializes in the legal cannabinoid market and leverages a robust network of operating advisors with expertise in healthcare, technology, consumer marketing, and regulatory affairs to support its portfolio companies.
What is the geographic focus of Intrinsic Capital Partners?
The firm primarily invests in North America, specifically within the United States, targeting companies that are innovating in the legal cannabinoid space.
What is the typical check size for investments?
While specific check sizes are not disclosed, Intrinsic Capital Partners has a fund size of $102 million, indicating a capacity for significant investments across various stages of company development.
What kind of support do portfolio companies receive?
Intrinsic Capital Partners provides its portfolio companies with access to a network of operating advisors who offer guidance in areas such as healthcare, technology, consumer marketing, and regulatory affairs, helping them navigate challenges and capitalize on opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.